Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Nightingale Health

2.00 EUR+2.30 %6/11 17:29
4,827 following

HEALTH

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Short Selling
Investor views
Compare
+2.30 %
+69.49 %
+135.29 %
+94.17 %
-2.44 %
-14.89 %
+88.68 %
-39.58 %
-61.17 %

Nightingale Health operates in the medical technology sector. The company specializes in the development of medical technology products. The product portfolio is broad and includes platforms and services within blood analysis that are used for disease prevention purposes. In addition to the main business, service and related ancillary services are also offered. The business is operated globally with the largest presence in Europe.

Read more
Market cap
121.88M EUR
Turnover
453.62K EUR
P/E (adj.) (27e)
-9.39
EV/EBIT (adj.) (27e)
-7.13
P/B (27e)
3.14
EV/S (27e)
6.71
Dividend yield-% (27e)
-
Coverage
Recommendation
Accumulate
Target price
1.60 EUR
Updated
2026-11-03
Disclaimer
Antti Luiro
Antti Siltanen
Antti Siltanen, Antti Luiro
Show more
Latest research

Latest analysis report

Released: 2026-11-03

Latest extensive report

Released: 2025-06-13

Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types

Forum discussions
Inderes Nightingale Healthin sairastumisriskien tunnistus osaksi lontoolaisen Barnes... Nightingale Health Oyj | Lehdistötiedote | 06.11.2026 klo 11:00:00 EETNightingale Health (Nasdaq Helsinki: HEALTH; OTCQX: NHLTY, NGHLF), sairastumisriskien tunnistamisen ja ennaltaehkäisevän.....
yesterday
by Pertti
15
Now! Inderes Nightingale Health etenee Yhdysvalloissa: New Yorkin osavaltio hyväksyi... Nightingale Health Oyj | Lehdistötiedote | 05.11.2026 klo 09:45:00 EETNightingale Health (Nasdaq Helsinki: HEALTH; OTCQX: NHLTY, NGHLF), sairastumisriskien tunnistamisen ja ennaltaehkäisevän.....
11/5/2026, 7:50 AM
by Pertti
14
Now NG has tapped into a goldmine. If this launch takes off, they won’t need anything else. Aging and the beauty business are areas where money seems to lose all meaning when people are chasing eternal youth. Fantastic move!
11/4/2026, 9:00 AM
by Maikki
12
This wasn’t the first deal in this sector. If I recall correctly, a similar one came through for the US in the fall. So the direction is damn good!
11/4/2026, 11:30 AM
by Ossi
9
Well, well. It could be that these continuous little breadcrumbs of news are (no longer so weak) signals of an impending tsunami. And these have been dropping for the third year now. Hopefully, the perfectly timed documentary about Elizabeth Holmes (Theranos) will add even more grist...
yesterday
by Balle Ramsted - pienehkö kasvusijoittaja nupullaan
7
Fortunately, this post of mine from September aged poorly, as I believe as many as 11 deals have already been closed since then! Nice progress, which in my opinion isn’t yet fully reflected in the stock’s valuation.
11/4/2026, 8:13 AM
by Yariskuski
7
It is important to note that, according to the release, approval has currently only been granted for certain individual blood biomarkers. According to the company’s website, the measurement currently includes around 250+ blood biomarkers, so we will still have to wait before the ...
11/5/2026, 8:13 AM
by Satunnaisotanta
4
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
9/3
2027

Interim report Q2'27

Press release2026-11-06 10:00

Nightingale Health's disease risk detection becomes part of annual health assessments at Barnes Private Practice in London

Nightingale Health
Regulatory press release2026-11-05 16:25

Resolutions of the Annual General Meeting and the Board of Directors’ organizational meeting of Nightingale Health Plc

Nightingale Health
Press release2026-11-05 08:45

Nightingale Health reaches next milestone in the United States: first laboratory developed tests approved by New York State

Nightingale Health

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2026-11-04 08:00

Nightingale Health's disease risk detection becomes part of a longevity membership at S-Thetics Clinic in the United Kingdom

Nightingale Health
Nightingale: Contracts keep flowing
Research2026-11-03 09:04
by Antti Siltanen, Antti Luiro

Nightingale: Contracts keep flowing

The company has received 3 proteomics orders in a short space of time.

Nightingale Health
Press release2026-11-02 14:00

Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study

Nightingale Health
Nightingale’s deal flow keeps a healthy beat
Analyst Comment2026-10-29 08:05
by Antti Siltanen

Nightingale’s deal flow keeps a healthy beat

The new contracts put upward pressure on our forecasts for the current financial year.

Nightingale Health
Regulatory press release2026-10-28 20:15

Inside information: Nightingale Health signs USD 1 million proteomics agreement with Alzheimer's Research UK, for neurodegenerative disease research

Nightingale Health
Regulatory press release2026-10-28 15:35

Inside information: Nightingale Health signs USD 1 million proteomics agreement with LifeArc, for neurodegenerative disease research

Nightingale Health
Analyst Comment2026-10-23 07:56
by Antti Siltanen

Nightingale's tests added to health assessments offered by British The Private GP Group

The new contract integrates blood analyses as part of health assessments.

Nightingale Health
Press release2026-10-22 08:30

Nightingale Health's disease risk detection becomes part of annual health assessments at The Private GP Group in the United Kingdom

Nightingale Health
Nightingale: Growth boost from proteomics
Research2026-10-08 09:01
by Antti Siltanen, Antti Luiro

Nightingale: Growth boost from proteomics

The protein analysis project will generate significant growth for the current fiscal year.

Nightingale Health
Nightingale's tests integrated into Siun sote's health checks
Analyst Comment2026-10-06 08:11
by Antti Siltanen

Nightingale's tests integrated into Siun sote's health checks

North Karelia is adopting risk tests as part of statutory health checks.

Nightingale Health
Press release2026-10-05 09:10

Nightingale Health's disease risk detection becomes part of health checks for the unemployed in the Wellbeing Services County of North Karelia in Finland

Nightingale Health
Regulatory press release2026-10-01 16:15

Notice to the Annual General Meeting of Nightingale Health Plc

Nightingale Health
Nightingale secures a major 5.8 MEUR project with the Michael J. Fox Foundation
Analyst Comment2026-10-02 09:30
by Antti Luiro

Nightingale secures a major 5.8 MEUR project with the Michael J. Fox Foundation

To the best of our knowledge, this is the company’s most valuable commercial contract to date and demonstrates once again the company’s ability to carry out large-scale research projects.

Nightingale Health
Regulatory press release2026-10-01 07:30

Nightingale Health’s Annual Report for financial year 2025–2026 has been published

Nightingale Health
Regulatory press release2026-09-30 19:09

Inside information: Nightingale Health signs USD 6.5 million proteomics agreement with the Michael J. Fox Foundation for neurodegenerative disease research

Nightingale Health
Press release2026-09-29 08:00

Nightingale Health's disease risk detection becomes available in Latvia through Professor Skride's Heart Clinic

Nightingale Health
Regulatory press release2026-09-28 11:56

Conversion of Nightingale Health Plc’s Series A shares to Series B shares

Nightingale Health